Cargando…
Utilizing Liquid Biopsy for Treatment Management in Bone-Dominant Metastatic Breast Cancer: A Case Report
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer death among women in the United States. In clinical practice, the standard method to confirm metastatic disease and tailor treatment is to biopsy a metastatic site. Bone is the most common metastatic site, occ...
Autores principales: | Cheng, Shirley, Nguyen, Edward Tri, Fukui, Jami Aya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941792/ https://www.ncbi.nlm.nih.gov/pubmed/36825100 http://dx.doi.org/10.1159/000526642 |
Ejemplares similares
-
Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019) -
Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021) -
Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022) -
The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
por: Keup, Corinna, et al.
Publicado: (2023) -
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer
por: Keup, Corinna, et al.
Publicado: (2021)